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Abstract
This report focuses on recent policy, and academic and clinical developments in the therapeutic
management of sex offenders, including the need for more robust assessment and risk management
protocols. Information is provided on current thinking about psychological and pharmacological
interventions. Meta-analytic studies clearly indicate that cognitive behavioural and relapse prevention
programmes are the most effective intervention, but there is a small amount of literature suggesting
that pharmacological treatments may have some utility. With advances in our understanding of the
neural substrates of deviant sexual arousal we may be able to develop and trial novel
neuropharmacological agents that target dysfunctional neurochemical circuits in this field.
Introduction and context
Increasing public concern about sexual offending and
the risks these offenders pose in the community has led
to a wave of new legislative measures to monitor and
manage this group in the UK and elsewhere. For
example, the Violent and Sex Offenders Register
(ViSOR) 2003 and the Sexual Offence Prevention Orders
(SOPO) allow UK police and probation services to track
and locate high-risk offenders in the UK. In recent years
governments have also significantly increased resources
for probation services to run structured group-based
intervention programmes for sex offenders.
Sex offences account for approximately 1% of all
recorded crime in the UK (Home Office Statistics,
2006). Internationally, crime surveys suggest that
sexual assaults are more common than official reports
suggest, with under-reporting influencing the accuracy
of statistical recording. Sex offenders are a hetero-
geneous group and a number of attempts have been
made to categorise them based on offence type, victim
type, and motivation [1]. Victim-based typologies have
proved particularly difficult in light of evidence that
some offend against a range of male and female
victims, child and adult victims, and related and
unrelated victims [2].
A comprehensive clinical assessment is essential in
understanding the nature and motivation for the
perpetrator’s behaviour, their likely treatment needs,
and their future risk to society. Multiple sources of
information are required given the high levels of denial
and minimisation of the seriousness and impact of their
offences noted among sex offender cohorts [3]. Standard
assessments should cover developmental history, family
history, psychosexual history, relationships, education/
employment, substance misuse, psychiatric/medical
history, forensic history, and attitude to offending
behaviour.
Over the last two decades there has been a growth in
interest in the development of specific sex offender risk
assessment tools. Large-scale meta-analytic reviews [4,5]
have identified static risk predictors that have been
combined to develop sex offender risk prediction tools
such as the STATIC-99 [6] and the Sex Offender Risk
Appraisal Guide [7]. Although the latter measures can
predict sexual recidivism quite well, more recent work
has focused on identifying more dynamic risk factors
that inform sex offender treatment planning and
management, such as deviant sexual interests and
antisocial orientation [5]. This has resulted in the
development of assessment tools that combine static
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Offender Need Assessment Rating (SONAR) [8], Sexual
Violence Risk-20 (SVR-20) [9], Risk for Sexual Violence
Protocol (RSVP) [10], and Violence Risk Scale - Sexual
Offender Version (VRS-SO) [11].
Cognitive behavioural therapy (CBT) is the preferred
mode of treatment for sex offenders according to the
Association for the Treatment of Sexual Abusers (ATSA),
2001. In the UK the prison-based group Sex Offender
Treatment Programme (STOP) and its evaluation project
(STEP) have provided a robust evidence base to suggest
the value of long-term CBT-based interventions for sex
offenders [12,13]. The primary goals of these interven-
tions are to reduce the risk of reoffending by cognitive
restructuring. This includes challenging cognitive distor-
tions and attempts at justification and minimisation of
offending behaviour. It also looks at improving victim
empathy and enabling the perpetrator to develop
relapse prevention skills. Other key goals are to improve
social competence, for example, by improving self
esteem, managing negative emotional states, and pro-
blem solving [1,14].
Relapse prevention is another key area of work that can
help sex offenders, released into the community after
intensive CBT interventions, to identify person-specific
sequences of events/behaviours (such as cognitive
distortions, deviant sexual arousal, poor social skills,
and intimacy difficulties) that have previously lead them
to offend. As there are multiple pathways leading to
relapse and an increased risk of reoffending, it has been
suggested that clinicians should encourage a self-regula-
tion model and attempt to understand the perpetrator’s
deviant sexual offending behaviour in terms of their
victim approach strategy (for example, grooming, coer-
cing or threatening victims).
Previous meta-analyses on the efficacy of sex offender
treatment programmes have shown that CBT-based
interventions can decrease recidivism, but that this
decrease is modest [4,12,15].
Recent advances
Recently, a ‘pathways’ model of child sexual abuse has
been developed which can also be applied to adult
sexual assault [16]. The latter model suggests there are
four psychological mechanisms that operate distinctly or
interactively to lead to sex offending behaviour. These
include intimacy deficits, deviant sexual scripts (that is,
an internal representation of sexual behaviour that
deviates from the societal norm), emotional dysregula-
tion, and distorted cognitions. Each of these mechanisms
can form the basis of cognitive-behavioural intervention
programmes.
A number of studies looking into the clinical assessment
of sex offenders suggest that there are a range of
psychometric measures that have utility in assessing
distorted cognitions, personality factors, denial and
minimisation, and motivation to engage in treatment
[17]. Contradictory research findings have lead to
questions about the utility of penile plethysmography
in the assessment of sexual preferences and risk,
although there seems to be some evidence to support
its use in sub-typing rapists [18,19]. The use of post-
conviction polygraphy in disclosure of offending beha-
viour is currently the subject of much debate given
the generic problems that have been recorded
about strategies that can be used to deceive using this
measure [20].
Pharmacological treatments for reducing sexual drive,
and therefore sexual behaviour, include anti-androgens
and hormonal agents such as medroxyprogesterone
acetate (MPA), cyproterone acetate (CPA), luteinising
hormone-releasing hormone (LHRH) agonists and
selective serotonin re-uptake inhibitors (SSRIs). CPA
rather than MPA has been used more extensively across
continents, but both drugs have been shown to be
effective in reducing testosterone levels [19]. More recent
work has focused on LHRH, which is a hypothalamic
decapeptide that decreases testosterone and dihydrotes-
tersterone release through its inhibitory effects on
gonadotrophin secretion. Although most studies are
open-label and of small sample size, the findings suggest
that this agent has promise given its prolonged action
and the fact it can be administered intramuscularly or
subcutaneously, with fewer side effects than CPA and
MPA. Although there is little literature looking at the
effects of combining CBT with pharmacological treat-
ments, one small-scale study of five subjects suggested
that CBT combined with the LHRH agonist leuprolide
reduced paedophilic fantasies and masturbation (sup-
ported by objective measures of arousal), and none
of the cohort reoffended within the 2 years of the
study [21].
The use of SSRIs in sex offenders has been reported in the
literature for over 15 years but there have been no
published randomised control treatment trials using
these agents. There are a number of small-scale open-
label studies suggesting evidence of a reduction in sexual
obsessions over a short-term period [19,22]. The use of
SSRIs needs further scrutiny in terms of offender
pathology, study design, and outcome measurement.
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effects of relapse prevention programmes on recidivism
have failed to find significant treatment effects [23].
However, a very recent well-designed study from Canada
[11] suggests that long-term (over 20 years) recidivism
rates can be reduced in moderate- to high-risk offenders.
The latter study was based on a high-intensity CBT-
orientated inpatient sex offender programme that
focused on the ‘What Works’ principles of effective
correctional treatment [24-26]. Most reviews highlight
the need for high quality methodologically rigorous
studies that can be used in future meta-analytic studies
on sex offender treatment programmes.
As yet, there are only a limited number of studies
demonstrating the incremental value of adding dynamic
variables (such as deviant sexual interests and antisocial
orientation) to standardised, fairly static, risk assessment
tools [27-29]. The development and validation of
combined static and dynamic risk assessment tools
with a focus on risk management, such as the VRS-SO
scale, will be invaluable in driving evaluations on the
sex offender treatment programme. There has been a
limited, but nonetheless potentially significant, advance
in our understanding of the neural basis of deviant
sexual arousal, particularly in paedophilia. For example,
brain regions associated with the control of behaviour
that are involved in processing erotic stimuli in healthy
individuals have very recently been shown to have a
reduced level of activation in paedophilic patients during
paedophilic visual erotic stimulation [30]. This suggests
an impaired recruitment of key structures that might
contribute to an altered sexual interest of these patients
toward adults. Findings like these need to be replicated
as they will enhance our understanding of the nature of
dysfunction in the neural networks involved in deviant
sexual behaviour and may lead to more targeted
neurocognitive and neuropharmacological treatment
interventions.
Implications for clinical practice
There is now reasonable evidence to suggest CBT
combined with relapse prevention, intensive residential,
and community-based sex offender treatment pro-
grammes reduces the risk of recidivism. Further work is
needed to explore the effects of combined CBT and
pharmacological treatments. More work is also needed
on the development of manualised treatment protocols,
which are process oriented so that clinicians can assess
which aspects of the core programme result in a good
outcome in relation to offender profile, need, and risk.
The development and validation of a number of specific
risk assessment/management tools should help clini-
cians identify key treatment targets for offenders and
assist in the process of identifying those who will need
more intensive residential CBT and relapse prevention
programmes. Denial and minimization of offending
behaviour is a key challenge for clinicians working in this
field. Some work is being done on the use of post-
conviction polygraphy to detect non-disclosure, but it is
too early to advocate its use in routine clinical practice.
Much more rigorous pharmacological treatment trials
are required in the sex offender treatment field before
these agents can be seen as primary, or indeed routine,
adjunctive components of treatment planning.
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